|
1
|
Hislop AA: Fetal and postnatal anatomical
lung development. Neonatal Respiratory Disorders. Greenough A and
Milner AD: (2nd). (London). Arnold Press. 247–251. 2003.
|
|
2
|
Ozturk MA, Gunes T, Koklu E and Erciyes A:
Free carnitine levels in respiratory distress syndrome during the
first week of life. Am J Perinatol. 23:445–459. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Korkmaz A, Tekinalp G, Coskun T, Yigit S
and Yurdakok M: Plasma carnitine levels in preterm infants with
respiratory distress syndrome. Pediatr Int. 47:49–52. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harmeyer J: The physiological role of
L-carnitine. Lohninger Information. 27:1–8. 2002.
|
|
5
|
Czeszyńska MB: Evaluation of fetal lung
maturation in rabbits after giving carnitine and carnitine with
betamethasone to pregnant rabbits. Ann Acad Med Stetin. 39:185–205.
1993.(In Polish). PubMed/NCBI
|
|
6
|
Salzer H, Husslein P, Lohninger A,
Binstorfer E, Langer M, Schönbauer M, Wagner G, Simbruner G and
Popow C: 1st report: Alternatives to cortisone therapy, 1st
clinical experiences with a carnitine-betamethasone combination for
the stimulation of the fetal lung maturity. Wien Klin Wochenschr.
95:724–728. 1983.(In German). PubMed/NCBI
|
|
7
|
Whitfield J, Smith T, Sollohub H, Sweetman
L and Roe CR: Clinical effects of L-carnitine supplementation on
apnea and growth in very low birth weight infants. Pediatrics.
111:477–482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar M, Kabra N and Paes B: Role of
carnitine supplementation in apnea of prematurity: A systematic
review. J Perinatol. 24:158–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kurz C, Arbeiter K, Obermair A, Salzer H,
Salzer HR and Lohninger A: L-carnitine-betamethasone combination
therapy versus betamethasone therapy alone in prevention of
respiratory distress syndrome. Z Geburtshilfe Perinatol.
197:215–219. 1993.(In German). PubMed/NCBI
|
|
10
|
Ballard JL, Khoury JC, Wedig K, Wang L,
Eilers-Walsman BL and Lipp R: New Ballard Score, expanded to
include extremely premature infants. J Pediatr. 119:417–23. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jackson JC: Respiratory distress in the
preterm infant. Avery's Diseases of the Newborn. Gleason CA and
Devaskar US: (9th). (Philadelphia, PA). Elsevier Saunders. 633–646.
2012. View Article : Google Scholar
|
|
12
|
Jobe AH and Bancalar E: Hormoncuklardan
dysplasia. Am J Respir Crit Care Med. 163:1723–1729. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carlo WA: The newborn infant. Nelson
Textbook of Pediatrics. Kliegman RM, Stanton BF, St. Geme JF III,
Schor NF and Behrman RE: (19th). (Philadelphia, PA). Elsevier
Saunders Press. 561–569. 2011.
|
|
14
|
Schulz KF, Altman DG and Moher D: CONSORT
Group: CONSORT 2010 Statement: Updated guidelines for reporting
parallel group randomised trials. BMC Med. 8:182010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bancalari E and Claure N: Principles of
respiratory monitoring and therapy. Avery's dıseases of the
newborn. Gleason CA and Devaskar SU: (9th). (Philadelphia, PA).
Elseiver Saunders Press. 612–632. 2012. View Article : Google Scholar
|
|
16
|
Douma C, Dawodu T and Patnode R: Appendix
A: Common NICU medication guidelines. Manuel of Neonatal Care.
Cloherty JH, Eichenwald EC and Stark AR: (6th). (Philadelphia, PA).
Lippincott Williams & Wilkins. 675–715. 2008.
|
|
17
|
Eichenwald EC: Mechanical ventilation.
Manuel of Neonatal Care. Cloherty JP, Eichenwald EC and Stark AR:
(6th). (Philadelphia, PA). Lippincott Williams & Wilkins.
331–343. 2008.
|
|
18
|
British Columbia Reproductive Care
Program: Newborn Guideline 6: Surfactant replacement therapy in
neonates. British Columbia Reproductive Care Program (British
Columbia, Canada). 2003.
|
|
19
|
Lohninger A, Krieglsteiner HP, Hajos F,
Stangl H and Marz R: Effects of prenatal treatment with
betamethasone, L-carnitine, or betamethasone-L-carnitine
combinations on the phosphatidylcholine content and composition of
the foetal and maternal rat lung. Eur J Clin Chem Clin Biochem.
34:387–391. 1996.PubMed/NCBI
|
|
20
|
Crill CM, Storm MC, Christensen ML,
Hankins CT, Jenkins Bruce M and Helms RA: Carnitine supplementation
in premature neonates: Effect on plasma and red blood cell total
carnitine concentrations, nutrition parameters and morbidity. Clin
Nutr. 25:886–896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lohninger A, Krieglsteiner HP, Salzer H,
Erhardt W, Eppl W and Kaiser E: Studies on the effects of
L-thyroxine, L-carnitine and an L-thyroxine-L-carnitine combination
on dipalmitoyl phosphatidylcholine content and on
phosphatidylcholine species composition in fetal rat lungs. Pediatr
Res. 20:1280–1283. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goñi FM, Requero MA and Alonso A:
Palmitoylcarnitine, a surface-active metabolite. FEBS Lett.
390:1–5. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arenas J, Huertas R, Campos Y, Díaz AE,
Villalón JM and Vilas E: Effects of L-carnitine on the pyruvate
dehydrogenase complex and carnitine palmitoyl transferase
activities in muscle of endurance athletes. FEBS Lett. 341:91–93.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Novak M: Carnitine in perinatal metabolism
of lipids. L-Carnitine and its Role in Medicine: From Function to
Therapy. Ferrari R, Di Mauro S and Sherwood G: (2nd). (London and
New York). Academic Press. 104–112. 1992.
|
|
25
|
Hiatt WR, Regensteiner JG, Wolfel EE, Ruff
L and Brass EP: Carnitine and acylcarnitine metabolism during
exercise in humans. Dependence on skeletal muscle metabolic state.
J Clin Invest. 84:1167–1173. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meyburg J, Schulze A, Kohlmueller D,
Pöschl J, Linderkamp O, Hoffmann GF and Mayatepek E: Acylcarnitine
profiles of preterm infants over the first four weeks of life.
Pediatric Res. 52:720–723. 2002. View Article : Google Scholar
|
|
27
|
Giannocopoulou C, Evangeliou A,
Matalliotakis I, Relakis K, Sbirakis N, Hatzidaki E and Koumandakis
E: Effect of gestation age and birth weight in the concentration of
carnitine in the umbilical plasma. Clin Exp Obstet Gynecol.
25:42–45. 1998.PubMed/NCBI
|
|
28
|
Zaharia G, Ion DA, Schmidt N, Popa M,
Kudor-Szabadi I and Zaharia T: Prophylactic versus therapeutic CPAP
in preterm newborns of 28–32 gestational weeks. Pneumonologia.
57:34–37. 2008.(In Romanian).
|
